SW
VRTX icon

SVB Wealth’s Vertex Pharmaceuticals VRTX Stock Holding History

SVB Wealth’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$558K Sell
1,123
-1,721
-61% -$763K 0.04% 260
2026
Q1 		$1.27M Sell
2,844
-217
-7% -$101K 0.08% 172
2025
Q4 		$1.39M Sell
3,061
-4,354
-59% -$1.88M 0.08% 178
2025
Q3 		$2.9M Sell
7,415
-92
-1% -$38.4K 0.16% 119
2025
Q2 		$3.34M Sell
7,507
-3,129
-29% -$1.44M 0.18% 117
2025
Q1 		$5.16M Sell
10,636
-4,527
-30% -$2.11M 0.21% 56
2024
Q4 		$6.11M Buy
+15,163
New +$7.03M 0.11% 121
2024
Q3 		– Sell
-17,201
Closed -$8.06M – 604
2024
Q2 		$8.06M Buy
17,201
+63
+0.4% +$27.3K 0.2% 114
2024
Q1 		$7.16M Sell
17,138
-56
-0.3% -$23.7K 0.16% 138
2023
Q4 		$7M Sell
17,194
-148
-0.9% -$54.7K 0.17% 137
2023
Q3 		$6.03M Sell
17,342
-211
-1% -$73.8K 0.13% 137
2023
Q2 		$6.18M Sell
17,553
-474
-3% -$160K 0.11% 147
2023
Q1 		$5.68M Sell
18,027
-433
-2% -$130K 0.08% 165
2022
Q4 		$5.33M Sell
18,460
-264
-1% -$80.5K 0.07% 170
2022
Q3 		$5.42M Buy
18,724
+1,559
+9% +$449K 0.08% 162
2022
Q2 		$4.84M Buy
17,165
+297
+2% +$79.5K 0.07% 152
2022
Q1 		$4.4M Buy
16,868
+496
+3% +$118K 0.06% 156
2021
Q4 		$3.6M Buy
16,372
+98
+0.6% +$19.1K 0.06% 167
2021
Q3 		$2.95M Sell
16,274
-812
-5% -$159K 0.04% 211
2021
Q2 		$3.44M Buy
17,086
+321
+2% +$67.1K 0.04% 201
2021
Q1 		$3.6M Buy
16,765
+1,345
+9% +$295K 0.05% 184
2020
Q4 		$3.64M Buy
15,420
+343
+2% +$78.7K 0.05% 182
2020
Q3 		$4.1M Buy
15,077
+973
+7% +$268K 0.07% 167
2020
Q2 		$4.09M Buy
14,104
+475
+3% +$129K 0.08% 148
2020
Q1 		$3.24M Sell
13,629
-443
-3% -$102K 0.08% 145
2019
Q4 		$3.08M Buy
14,072
+207
+1% +$41.9K 0.06% 168
2019
Q3 		$2.35M Buy
13,865
+540
+4% +$95.5K 0.05% 186
2019
Q2 		$2.44M Hold
13,325
– – 0.08% 184
2019
Q1 		$2.45M Sell
13,325
-44
-0.3% -$8.13K 0.1% 141
2018
Q4 		$2.21M Sell
13,369
-144
-1% -$25K 0.09% 143
2018
Q3 		$2.6M Sell
13,513
-208
-2% -$37K 0.09% 151
2018
Q2 		$2.33M Sell
13,721
-125
-0.9% -$19.4K 0.09% 160
2018
Q1 		$2.26M Sell
13,846
-245
-2% -$40K 0.09% 171
2017
Q4 		$2.11M Sell
14,091
-782
-5% -$116K 0.08% 178
2017
Q3 		$2.26M Buy
14,873
+18
+0.1% +$2.71K 0.09% 171
2017
Q2 		$1.91M Hold
14,855
– – 0.08% 194
2017
Q1 		$1.62M Sell
14,855
-3,455
-19% -$304K 0.06% 203
2016
Q4 		$1.35M Sell
18,310
-571
-3% -$46.5K 0.06% 217
2016
Q3 		$1.65M Sell
18,881
-1,153
-6% -$109K 0.07% 202
2016
Q2 		$1.72M Sell
20,034
-1,551
-7% -$134K 0.07% 202
2016
Q1 		$1.72M Sell
21,585
-853
-4% -$77.2K 0.07% 206
2015
Q4 		$2.82M Sell
22,438
-883
-4% -$107K 0.11% 163
2015
Q3 		$2.43M Sell
23,321
-2,894
-11% -$372K 0.09% 191
2015
Q2 		$3.24M Buy
26,215
+420
+2% +$52.9K 0.11% 181
2015
Q1 		$3.04M Buy
25,795
+920
+4% +$110K 0.1% 188
2014
Q4 		$2.96M Buy
+24,875
New +$2.8M 0.1% 189

Other funds holding VRTX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
CTB
Country Trust Bank Bloomington, Illinois $5.71B AUM 25.48% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
GIA
Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return
MLL
Moody Lynn & Lieberson Boston, Massachusetts $1.9B AUM 27.82% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.87B AUM 24.22% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return

SVB Wealth's VRTX Position: Q2 2026 in Review

SVB Wealth reduced its Vertex Pharmaceuticals (VRTX) stake by 61% in Q2 2026, selling an estimated $763K and leaving 1,123 shares worth $558K. The position accounts for 0.04% of the portfolio, ranked #260.

SVB Wealth first reported a position in VRTX in Q4 2014 and has held it in 46 quarters since. The position peaked at $8.06M in Q2 2024. 296 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • SVB Wealth held 1,123 shares of Vertex Pharmaceuticals worth $558K as of Q2 2026.
  • SVB Wealth sold 1,721 Vertex Pharmaceuticals shares in Q2 2026, an estimated $763K.
  • Vertex Pharmaceuticals made up 0.04% of SVB Wealth's portfolio in Q2 2026, its #260 holding.
  • SVB Wealth first reported a position in Vertex Pharmaceuticals in Q4 2014 and has held it in 46 quarters since.
  • SVB Wealth's Vertex Pharmaceuticals position peaked at $8.06M in Q2 2024.
  • 296 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on SVB Wealth's 13F filing for Q2 2026, filed 17 Jul 2026.